Is This The Final Blow For The Accutane Litigation?

Last year we posted about two major decisions by the New Jersey Supreme Court finally chopping the Accutane inflammatory bowel disease ("IBD") litigation down to size. Our post here contains links to all of our posts over the years on the Accutane litigation. The point of note is that to get to those two decisions took years. In both situations, the trial court made terrific defense rulings on plaintiffs' inadequate experts and the adequacy of the drug's warnings. Both of which were overturned by the Appellate Division only to be affirmed by the New Jersey Supreme Court. So, when the trial court tossed out plaintiffs' remaining experts back in 2017, we wondered if we were in for another lengthy roller coast ride through the New Jersey court system. But this time we think the journey will conclude at the Appellate Division, and that's a good development.